-
Awakn Life Sciences’ new psychedelic drug treatment for alcohol addiction moving to clinical trial
As we all know alcohol addiction is one of the worst addictions in society costing billions per year.…
-
Dev Randhawa on Fission 3.0’s private placement and the uranium market
In a recent InvestorIntel interview, Peter Clausi spoke with Dev Randhawa, Chairman and CEO of Fission 3.0 Corp. (TSXV: FUU…
-
Dr. Allen Davidoff of XORTX Therapeutics’ on developing therapies for kidney diseases and uplisting to the NASDAQ
In a recent InvestorIntel interview, Chris Thompson spoke with Dr. Allen Davidoff, CEO of XORTX Therapeutics Inc. (NASDAQ:…
-
How hosting infrastructure for data centers and crypto mining operations may be the missing link
Everyone has heard of cryptocurrency mining and data centers by now; but have you heard of a company…
-
Permitted and Production ready, the Sunday Mornin’ Mine is Comin’ Alive to Mine Saleable Uranium
It’s been a wild ride for uranium stocks over the last few months. From mid-August into September there…
-
Chris Thompson with Justin Cochrane on Carbon Streaming’s first Blue Carbon Credit Project
In a recent InvestorIntel interview, Chris Thompson spoke with Justin Cochrane, Founder, Director and CEO of Carbon Streaming Corporation (NEO:…
